Cargando…

Anti-fibrotic therapy for the treatment of pulmonary sequelae in patients healed by COVID-19

Detalles Bibliográficos
Autores principales:	Vitiello, Antonio, Ferrara, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104335/ https://www.ncbi.nlm.nih.gov/pubmed/33687000 http://dx.doi.org/10.4103/lungindia.lungindia_803_20

Ejemplares similares

Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2021)

COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy
por: Vitiello, Antonio, et al.
Publicado: (2020)

Are there pulmonary sequelae in patients recovering from COVID-19?
por: Rogliani, Paola, et al.
Publicado: (2020)

Remdesivir versus ritonavir/lopinavir in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2020)

COVID-19 global pandemic: vaccines and new monoclonal antibodies, aspects to be clarified
por: Ferrara, Francesco, et al.
Publicado: (2021)

Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks?
por: Vitiello, Antonio, et al.
Publicado: (2021)

COVID-19 vaccination in pregnancy
por: Vitiello, Antonio, et al.
Publicado: (2021)

The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2: Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection?
por: Ferrara, Francesco, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Ferrara, Francesco, et al.
Publicado: (2020)

COVID-19 pandemic: vaccine and new monoclonal antibodies, point of view
por: Vitiello, Antonio, et al.
Publicado: (2021)

Pulmonary sequelae of pediatric patients after discharge for COVID‐19: An observational study
por: Zhang, Che, et al.
Publicado: (2021)

Pulmonary sequelae of swine flu
por: Joob, Beuy, et al.
Publicado: (2013)

Probiotics for the Prevention of COVID-19 Sequelae
por: KOW, CHIA SIANG, et al.
Publicado: (2022)

COVID-19, vaccination and neuropsychiatric sequelae: Correspondence
por: Yasri, Sora, et al.
Publicado: (2022)

Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?
por: Ferrara, Francesco, et al.
Publicado: (2020)

Adrenal insufficiency as a post-COVID-19 sequela
por: Katikar, Manisha D
Publicado: (2021)

Critical Illness Polyneuropathy as a Sequelae of COVID-19
por: Bawiskar, Nipun, et al.
Publicado: (2022)

Neuro-ophthalmic Sequelae in COVID-19 Recovered Cases
por: Kene, Rakshita D, et al.
Publicado: (2022)

Correspondence: Neuropsychiatric post-acute sequelae of COVID-19
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Organizing pneumonia as a pulmonary sequela of swine flu
por: Zanetti, Gláucia, et al.
Publicado: (2013)

HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19
por: Roncati, Luca, et al.
Publicado: (2021)

Driving pressure and adjunctive therapies in pulmonary sequelae of COVID-19 patients under invasive ventilation
por: González, Jessica, et al.
Publicado: (2023)

A brewing storm: The neuropsychological sequelae of hyperinflammation due to COVID-19
por: Cothran, Thomas P., et al.
Publicado: (2020)

COVID-19-negative psychiatric units: Mitigating sequelae of pandemic isolation
por: Kostro, Katrina Brody, et al.
Publicado: (2021)

Lupus anticoagulant hypoprothrombinemia syndrome - could it be a sequelae of COVID-19?
por: Stjepovic, Nusa Matijasic, et al.
Publicado: (2023)

Sulodexide: A Benefit for Cardiovascular Sequelae of Long COVID Patients?
por: Szolnoky, Győző, et al.
Publicado: (2022)

Applicability of the chronic obstructive pulmonary disease assessment test as a measure of health status in patients with sequelae of pulmonary tuberculosis
por: Torres, Diego de Faria Magalhães, et al.
Publicado: (2021)

Looking at the day after COVID-19… what laryngeal sequelae should we expect?
por: Torretta, Sara, et al.
Publicado: (2021)

Persistent dysregulation of cellular immunity following COVID-19 recovery despite minimal post-COVID-19 sequelae manifestation
por: Putri, Denise Utami, et al.
Publicado: (2023)

Facial Scars Due to Prone Position Pressure Ulcers: Underestimated Sequelae in COVID-19 Survivors?
por: Schols, Rutger M, et al.
Publicado: (2021)

Risk of new‐onset psychiatric sequelae of COVID‐19 in the early and late post‐acute phase
por: Coleman, Ben, et al.
Publicado: (2022)

Comment on: Bariatric surgery in patients with previous COVID-19 infection
por: Vitiello, Antonio, et al.
Publicado: (2021)

Anti-fibrotic Treatment for Pulmonary Fibrosis Induced by COVID-19: A Case Presentation
por: Sakızcı Uyar, Bahar, et al.
Publicado: (2022)

Severe interstitial lung disease persisting 2 years post-COVID-19 despite anti-fibrotic therapy
por: Udwadia, Zarir F., et al.
Publicado: (2022)

Does COVID-19 increase the risk of neuropsychiatric sequelae? Evidence from a mendelian randomization approach
por: Tirozzi, Alfonsina, et al.
Publicado: (2022)

Risk of drug-induced cardiac arrhythmia during COVID-19 therapeutic treatment
por: Vitiello, Antonio, et al.
Publicado: (2021)

Fibrotic interstitial lung disease occurring as sequelae of COVID-19 pneumonia despite concomitant steroids
por: Udwadia, Zarir Farokh, et al.
Publicado: (2021)

Long-term sequelae of TB and COVID-19 co-infection: Prospective cohort evaluation after 1 year
por: Silva, D.R., et al.
Publicado: (2023)

A short focus, azithromycin in the treatment of respiratory viral infection COVID-19: efficacy or inefficacy?
por: Vitiello, Antonio, et al.
Publicado: (2021)

Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
por: Ferrara, Francesco, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jbno4b03la9lht1rild49h7r3h